ARCHIVES

FDA Committee Okays High Dose Methotrexate, Mitxantrone In ANL; reverse Breast Cancer Vote

This article is from The Cancer Letter archive.

Vol. 13 No. 48 | December 11, 1987

Download PDF Visit The Full Archive

Related Articles

Chabner Says Some Group Satellites Causing Concern Because Of Lack Communications

March 4, 1983

DeVita Defends CHP Awards, Says Program Has High Priority

September 5, 1980

Oxandrolone And Education Improves Weight Gain

February 28, 2003

In Brief: Henry Kaplan Dies Of Lung Cancer At 65; LED Development Of Hodgkin’s Disease Treatment

February 10, 1984

As Zeneca Buys Salick, Implications For Oncology Managed Care Uncertain

April 4, 1997

European Treatment Regimen Less Toxic Than American Method

April 26, 2013